MedTrace Logo

Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke

NCT07735338 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-07-30

No results posted yet for this study

Summary

To assess the diagnostic accuracy of a smartphone application in predicting heart attack or stroke within 3-4 days in high-risk patients.

Conditions

  • Myocardial Infarction (MI)
  • Stroke

Interventions

DEVICE

Smartphone application Antshrike

All participants will wear a smart watch that has an application Antshrike, which will collect demographic data, health history, lifestyle factors, and biobehavioral data for 18 months.

Sponsors & Collaborators

  • Before Health Intelligence Ltd

    collaborator UNKNOWN

  • Samsung Electronics Co., Ltd

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Principal Investigators

  • Sandra Tsai, MD · Stanford University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2030-10-31
Completion
2030-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07735338 on ClinicalTrials.gov